(R)-N-((S)-1-((S)-6-amino-1-(4-((3S,4R)-1-(3,5-bis(trifluoromethyl)benzoyl)-3-phenylpiperidin-4-yl)piperazin-1-yl)-1-oxohexan-2-ylamino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanamido)-5-guanidinopentanamide

ID: ALA3780776

Chembl Id: CHEMBL3780776

PubChem CID: 127032533

Max Phase: Preclinical

Molecular Formula: C56H71F6N11O6

Molecular Weight: 1108.24

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCN([C@@H]2CCN(C(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@@H]2c2ccccc2)CC1

Standard InChI:  InChI=1S/C56H71F6N11O6/c1-34-26-41(74)27-35(2)42(34)32-44(64)49(75)68-45(17-11-20-67-54(65)66)50(76)70-47(28-36-12-5-3-6-13-36)51(77)69-46(16-9-10-19-63)53(79)72-24-22-71(23-25-72)48-18-21-73(33-43(48)37-14-7-4-8-15-37)52(78)38-29-39(55(57,58)59)31-40(30-38)56(60,61)62/h3-8,12-15,26-27,29-31,43-48,74H,9-11,16-25,28,32-33,63-64H2,1-2H3,(H,68,75)(H,69,77)(H,70,76)(H4,65,66,67)/t43-,44+,45-,46+,47+,48-/m1/s1

Standard InChI Key:  WCJDWNUHDMSTQS-QEHHYHKYSA-N

Alternative Forms

  1. Parent:

    ALA3780776

    ---

Associated Targets(Human)

TACR1 Tclin Neurokinin 1 receptor (6273 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

OPRM1 Mu opioid receptor (3620 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprd1 Delta opioid receptor (3127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprm1 Mu opioid receptor (6060 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprd1 Delta opioid receptor (3911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1108.24Molecular Weight (Monoisotopic): 1107.5493AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Betti C, Starnowska J, Mika J, Dyniewicz J, Frankiewicz L, Novoa A, Bochynska M, Keresztes A, Kosson P, Makuch W, Van Duppen J, Chung NN, Vanden Broeck J, Lipkowski AW, Schiller PW, Janssens F, Ceusters M, Sommen F, Meert T, Przewlocka B, Tourwé D, Ballet S..  (2015)  Dual Alleviation of Acute and Neuropathic Pain by Fused Opioid Agonist-Neurokinin 1 Antagonist Peptidomimetics.,  (12): [PMID:26713106] [10.1021/acsmedchemlett.5b00359]

Source